Across TCGA pan-cancer cohorts, LINC01034 RNA differs between tumor and matched normal tissue in 4 of 18 cancer types tested, making tumor–normal expression one of LINC01034’s most consistent transcriptional readouts.

The strongest signal is observed in uterine corpus endometrial carcinoma (UCEC), where LINC01034 RNA is repressed in tumor relative to normal tissue. In most cancer types LINC01034 is over-expressed in tumor, although a few such as UCEC and BRCA show the opposite, repressed pattern.

UCEC, BRCA, and THCA are the cancer types where LINC01034 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in LINC01034 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
UCEC	All	All	−0.348	<.001	6	view →
BRCA	All	All	−0.085	.001	4	view →
THCA	All	All	−0.078	.004	2	view →
KICH	Male	All	+0.209	.033	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 4 strongest of 4 lineages.

Exploration

Same gene, other analysis: LINC01034 RNA expression & survival · all LINC01034 data types